Semaphorin-3A protects against neointimal hyperplasia after vascular injury
Authors:
Open Access
- 1 January 2019
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 39, 95-108
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2018YFC1312200, 2016YFC1300600)
- National Natural Science Foundation of China (81571119, 81601027, 81571139, 81771249, 81400969, 81400970, 81301001)
- Natural Science Foundation of Hubei Province of China (2016CFB518)
- National Research Foundation for the Doctoral Program of Higher Education of China (20120142110068)
- New Century Excellent Talents in University (NCET-10-0406)
This publication has 52 references indexed in Scilit:
- 40 Years of Percutaneous Coronary Intervention: History and Future DirectionsJournal of Personalized Medicine, 2018
- Restenosis, Stent Thrombosis, and Bleeding ComplicationsJACC, 2018
- Cardiovascular disease: Biochemistry to behaviourNature, 2013
- Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formationBasic Research in Cardiology, 2012
- Smooth muscle cell phenotypic switching in atherosclerosisCardiovascular Research, 2012
- Pathogenesis of Neointima Formation Following Vascular InjuryCardiovascular & Hematological Disorders-Drug Targets, 2011
- The Pathophysiology and Burden of RestenosisThe American Journal of Cardiology, 2007
- Sirolimus-Eluting Stents vs Paclitaxel-Eluting Stents in Patients With Coronary Artery DiseaseJAMA, 2005
- Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and DiseasePhysiological Reviews, 2004
- AtherosclerosisCell, 2001